For research use only. Not for therapeutic Use.
Elvitegravir-d6 is a deuterated form of elvitegravir, an antiretroviral drug used to treat HIV-1 infection. In this version, six hydrogen atoms are replaced with deuterium, which enhances its utility in pharmacokinetic and metabolic studies. The deuterium labeling allows for precise tracking and analysis in mass spectrometry and NMR spectroscopy, facilitating the study of the drug’s absorption, distribution, metabolism, and excretion. Despite the isotopic modification, elvitegravir-d6 retains the same therapeutic properties as the non-deuterated drug, making it valuable for research in HIV treatment.
| Catalog Number | R013324 |
| CAS Number | 1131640-69-1 |
| Synonyms | 6-[(3-Chloro-2-fluorophenyl)methyl]-1,4-dihydro-1-[(1S)-1-hydroxymethyl-2-methylpropyl]-7-methoxy-4-oxo-3-quinolinecarboxylic Acid-d5; GS 9137-d5; JTK 303-d5; ? |
| Molecular Formula | C₂₃H₁₇D₆ClFNO₅ |
| Purity | ≥95% |
| Storage | Store at -20 ℃ |
